MDxHealth Financial Statements From 2010 to 2025
| MDXH Stock | USD 1.57 0.09 6.08% |
Check MDxHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MDxHealth's main balance sheet or income statement drivers, such as , as well as many indicators such as . MDxHealth financial statements analysis is a perfect complement when working with MDxHealth Valuation or Volatility modules.
MDxHealth |
MDxHealth SA ADR Company Return On Asset Analysis
MDxHealth's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current MDxHealth Return On Asset | -0.11 |
Most of MDxHealth's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MDxHealth SA ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, MDxHealth SA ADR has a Return On Asset of -0.1079. This is 98.77% lower than that of the Biotechnology sector and 98.57% lower than that of the Health Care industry. The return on asset for all United States stocks is 22.93% lower than that of the firm.
MDxHealth SA ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MDxHealth's current stock value. Our valuation model uses many indicators to compare MDxHealth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MDxHealth competition to find correlations between indicators driving MDxHealth's intrinsic value. More Info.MDxHealth SA ADR is rated below average in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MDxHealth's earnings, one of the primary drivers of an investment's value.About MDxHealth Financial Statements
Investors use fundamental indicators, such as MDxHealth's revenue or net income, to determine how well the company is positioned to perform in the future. Although MDxHealth's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium. Mdxhealth operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 191 people.
Currently Active Assets on Macroaxis
When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock:Check out the analysis of MDxHealth Correlation against competitors. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MDxHealth. If investors know MDxHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MDxHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if MDxHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MDxHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.